782 related articles for article (PubMed ID: 24280293)
1. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
[TBL] [Abstract][Full Text] [Related]
2. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo.
Giersch K; Bhadra OD; Volz T; Allweiss L; Riecken K; Fehse B; Lohse AW; Petersen J; Sureau C; Urban S; Dandri M; Lütgehetmann M
Gut; 2019 Jan; 68(1):150-157. PubMed ID: 29217749
[TBL] [Abstract][Full Text] [Related]
5. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope.
Smedile A; Casey JL; Cote PJ; Durazzo M; Lavezzo B; Purcell RH; Rizzetto M; Gerin JL
Hepatology; 1998 Jun; 27(6):1723-9. PubMed ID: 9620349
[TBL] [Abstract][Full Text] [Related]
7. An update on HDV: virology, pathogenesis and treatment.
Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
[TBL] [Abstract][Full Text] [Related]
8. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
9. Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection.
Tsuge M; Uchida T; Walsh K; Ishida Y; Tateno C; Kumar U; Glenn JS; Koh C; Heller T; Uprichard SL; Dahari H; Chayama K
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875937
[No Abstract] [Full Text] [Related]
10. [The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people].
Xu PS; Han SY; Sun CY; Zhao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):307-9. PubMed ID: 23189853
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of hepatitis B and delta virus infection.
Dandri M; Lütgehetmann M
J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
[TBL] [Abstract][Full Text] [Related]
12. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
13. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M
J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
Lucifora J; Alfaiate D; Pons C; Michelet M; Ramirez R; Fusil F; Amirache F; Rossi A; Legrand AF; Charles E; Vegna S; Farhat R; Rivoire M; Passot G; Gadot N; Testoni B; Bach C; Baumert TF; Hyrina A; Beran RK; Zoulim F; Boonstra A; Büning H; Verrier ER; Cosset FL; Fletcher SP; Salvetti A; Durantel D
J Hepatol; 2023 May; 78(5):958-970. PubMed ID: 36702177
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro.
Shirvani-Dastgerdi E; Pourkarim MR; Herbers U; Amini-Bavil-Olyaee S; Yagmur E; Alavian SM; Trautwein C; Tacke F
Clin Microbiol Infect; 2016 Jan; 22(1):98.e1-98.e6. PubMed ID: 26433026
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
[TBL] [Abstract][Full Text] [Related]
18. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.
Giersch K; Homs M; Volz T; Helbig M; Allweiss L; Lohse AW; Petersen J; Buti M; Pollicino T; Sureau C; Dandri M; Lütgehetmann M
Sci Rep; 2017 Jun; 7(1):3757. PubMed ID: 28623307
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis delta virus. Genetics and pathogenesis.
Casey JL
Clin Lab Med; 1996 Jun; 16(2):451-64. PubMed ID: 8792082
[TBL] [Abstract][Full Text] [Related]
20. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Colagrossi L; Salpini R; Scutari R; Carioti L; Battisti A; Piermatteo L; Bertoli A; Fabeni L; Minichini C; Trimoulet P; Fleury H; Nebuloso E; De Cristofaro M; Cappiello G; Spanò A; Malagnino V; Mari T; Barlattani A; Iapadre N; Lichtner M; Mastroianni C; Lenci I; Pasquazzi C; De Sanctis GM; Galeota Lanza A; Stanzione M; Stornaiuolo G; Marignani M; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Perno CF; Coppola N; Svicher V
Viruses; 2018 Jul; 10(7):. PubMed ID: 29987240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
